Mersana Therapeutics, Inc. Soared
Tue, Aug 09, 2022 at 07:16 PM
Mersana Therapeutics, Inc. (MRSN:NASDAQ) jumped higher at $7, a gain of 33.3%. On Tue, Aug 09, 2022, MRSN:NASDAQ touched a New 2-Week High of $7. The stock appeared on our News Catalysts scanner on Tue, Aug 09, 2022 at 10:31 AM in the 'BIOTECH' category. From Tue, Jul 26, 2022, the stock recorded 50.00% Up Days and 54.55% Green Days
About Mersana Therapeutics, Inc. (MRSN:NASDAQ)
Mersana Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing antibody drug conjugates, or ADCs, that offer a clinically meaningful benefit for cancer patients with significant unmet need.
Top 10 Gainers:
- AeroClean Technologies Inc. (AERC:NASDAQ), 60.13%
- BBQ Holdings, Inc. (BBQ:NASDAQ), 46.59%
- Verona Pharma plc (VRNA:NASDAQ), 44.32%
- FaZe Holdings Inc. (FAZE:NASDAQ), 42.41%
- Mersana Therapeutics, Inc. (MRSN:NASDAQ), 33.33%
- Avalo Therapeutics Inc. (AVTX:NASDAQ), 32.14%
- Akanda Corp. (AKAN:NASDAQ), 30.21%
- Atara Biotherapeutics, Inc. (ATRA:NASDAQ), 29.2%
- ReTo Eco-Solutions, Inc. (RETO:NASDAQ), 25.85%
- D-Wave Quantum Inc. (QBTS:NYSE), 24%